Home » Merck Shingles Vaccine Effective in Adults in 50s
Merck Shingles Vaccine Effective in Adults in 50s
In a huge study aimed at broadening the use of Merck & Co’s shingles vaccine, Zostavax reduced the incidence of the painful disease by 70 percent compared with a placebo in adults in their 50s, the company said.
ForexPros
ForexPros
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May